Concord Drugs
Company Overview - January 14, 2025
Concord Drugs is a notable player in the Pharmaceuticals - Indian - Bulk Drugs & Formln industry, listed on the BSE (Code: 538965). As of the January 14, 2025, the company holds a market capitalization of INR 34.55 crores, placing it among the top-performing companies in its sector.
With a current stock price of INR 34.55, Concord Drugs has demonstrated a 3.73% return over the last year. Recent performance indicates fluctuations, with a -1.72% change in the past week and a -4.51% change over the last month. The company's all-time high stands at INR 91.25, while its lowest-ever price was INR 11.68.
In terms of sales, Concord Drugs reported a revenue of INR 45.28 crores, solidifying its position in the market. The average trading volume over the past month has been 7691 shares, with a more recent weekly average of 6133.
With the stock trading below its 50-day moving average of INR 36.59, the company's technical indicators like MACD (-0.42) signal negative trends.
Company Data
| Name | Concord Drugs |
|---|---|
| BSE Code | 538965 |
| NSE Code | |
| Industry | Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Current Price | 34.55 |
| Market Capitalization | 34.55 |
| Sales | 45.28 |
| Return over 3months | -2.32 |
| Return over 6months | -4.54 |
| Volume 1month average | 7691 |
| Volume 1week average | 6133 |
| Volume | 1340 |
| High price | 61.50 |
| Low price | 30.59 |
| High price all time | 91.25 |
| Low price all time | 11.68 |
| Return over 1day | -2.26 |
| Return over 1week | -1.72 |
| Return over 1month | -4.51 |
| Return over 1year | 3.73 |
| Return over 3years | 6.46 |
| Return over 5years | 15.84 |
| Volume 1year average | 20106 |
| DMA 50 | 36.59 |
| DMA 200 | 37.17 |
| DMA 50 previous day | 36.64 |
| DMA 200 previous day | 37.19 |
| MACD | -0.42 |
| MACD Signal | -0.26 |